Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2016

Strong growth in the Asia Pacific IC device market is being driven by rapid economic growth, which is increasing the prevalence of CAD, treatment availability, as well as patients’ ability to pay for treatment.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the IC device market in the Asia Pacific region, including country-level data for 13 major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…